Homebiotech

biotech

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Atopic dermatitis trial meets primary endpoint

Jim Cornall - July 21, 2026

biotech

Key to immunotherapy for intractable brain tumours discovered

Jim Cornall - July 21, 2026

biotech

Fast Track Designation for colorectal cancer treatment

Jim Cornall - July 20, 2026

biotech

AI helps predict which DNA sequences bind to each other

Jim Cornall - July 20, 2026

biotech

Boost for Niagen’s NAD+ programme

Jim Cornall - July 20, 2026

biotech

Base to Base biotech podcast 68: Water from air for pharma and beyond

Jim Cornall - July 17, 2026

biotech

New phase 1 data show potential for neurodegenerative disease treatment

Jim Cornall - July 16, 2026

biotech

Metabolic syndrome linked to faster brain ageing

Jim Cornall - July 16, 2026

1...567...96 Page 6 of 96

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

New norovirus vaccine approach may help treat other RNA viruses

Jim Cornall - August 25, 2026 0

On a genetic level, RNA viruses share common structural elements. The RNA of their genomes has strings, folds, and knot-like features that interact with...

Base to Base biotech podcast 72: Cell-free DNA bioproduction

biotech Jim Cornall - August 21, 2026 0

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0